logo
logo
  • About us
    • LTU School of Cancer Medicine
    • Our People
    • Our Partners
    • Our Corporate Publications
    • Our Policies
    • A message from our Founding Champion
  • Our Research
    • Research Programs
      • Cancer and Inflammation Program
        • Cancer and Inflammation Laboratory
        • Tumour Microenvironment and Cancer Signaling Group
        • Cancer Therapeutics Development Group
      • Cancer Immunobiology Program
        • Tumour Immunology Laboratory
        • Mucosal Immunity and Cancer Laboratory
      • Gastrointestinal Cancer Program
        • Oncogenic Transcription Laboratory
        • Cell Death and Survival Laboratory
      • Translational Breast Cancer Program
        • Metastasis Research Laboratory
        • Matrix Microenvironment and Metastasis Laboratory
        • Tumour Progression and Heterogeneity Laboratory
        • Cancer Single Cell Genomics Laboratory
      • Tumour Targeting Program
        • Tumour Targeting Laboratory
        • Receptor Biology Laboratory
      • Centre for Research Excellence in Brain Cancer
      • Bioinformatics and Cancer Genomics Laboratory
    • Research Platforms
      • The ACRF Centre for Translational Cancer Therapeutics and Imaging
      • The ACRF Centre for Imaging the Tumour Environment
      • VECTRA Multi-Spectral Imaging Platform
      • Mammalian Protein Expression Facility
      • Flow Cytometry Core Facility
  • Clinical Trials
  • Latest news
  • Join our team
    • Study opportunities
    • Career opportunities
    • Volunteer Opportunities
  • Contact us
  • Support us
  • Donate now
  • Search

Month: January 2021

Monepantel preclinical investigations to continue with PharmAust

Read More

Address

145 Studley Road, Heidelberg
3084 Victoria
Australia

(On the corner of Studley Rd and Bell St)

Call us

+61 3 9496 5726

Explore
    • Home
    • About us
    • Our research
    • Join our team
    • Clinical trials
    • Latest news
    • Contact us

Privacy Preference Center

Privacy Preferences